Glenmark Pharmaceuticals Limited in association with Americares India Foundation has initiated a week long awareness campaign on ‘Hypertension’ from May 15, 2017 to May 19, 2017 in Mumbai.
May 17th is observed world-wide as the ‘World Hypertension Day’ to create awareness about the silent killer. This year’s theme is ‘Know Your Numbers’, to raise awareness about the optimum blood pressure “120/80”. This joint initiative is conducted to commemorate “World Hypertension Day” observed on May 17 of each year across the world.
The weeklong screening & awareness campaign’s direct connective model shall include three modes namely Mobile medical clinics, Mass communication & awareness activity and Door to Door campaign for city’s marginalizepopulation. All three modes during the campaign week is likely to cover around 5,000 individual’s spread across Mumbai’s 70 locations dominating marginalize population.
Explaining the objective of this unique ‘120/80’ campaign, Mr. Sujesh Vasudevan, President and Head of India Formulations & Africa Region, Glenmark Pharmaceuticalssaid “Hypertension is a global public health challenge and major risk factor for cardiovascular mortality. This fact is important because hypertension is a controllable disease and a regular monitoring and life-style changes can help minimize the damage.This campaign aims to raise awareness, identify undetected cases of hypertension amongstunaware and uneducated marginalizecitizens living in the citythrough consultation and treatment.”
"Uncontrolled hypertension damages arteries, heart and other organs. While an uncontrolled high blood pressure has the potential of causing life threatening problems in the long term. The problem particularly becomes severe for underprivileged population living in urban areas were large proportion of individuals never get diagnosed for hypertension despite of possessing severe symptoms of disease." said Mr. Shripad Desai MD & Country Director, Americareshighlighting the importance of prevention against Hypertension.
Low income, job insecurity, poor living conditions add to the lack of awareness and ignorance among the marginalizepopulation. While majority is unaware about their high blood pressure, those who are detected are casual about treatment and lifestyle modifications that leads to further complications.
“I have been suffering from headache for past few days. Today when I came to the camp the doctor informed me that I may be suffering from high blood pressure. He has advised me to do regular exercise and reduce salt intake and visit the clinic again after 15 days.”said Ramlal a security guard who visited one such camp.
The campaign in Mumbai shall cover 70 marginalize populated locations through 07 mobile vans, catering to 5,000 individuals. The mobile clinics shall consult around 700 patients a day, while the volunteers will visit 400 individuals every day conducting on-the-spot testing for high-risk populations preferable those who were never tested for blood pressure before.
For more information;
Senior Manager, Corporate Communication
+91 98201 77907
MD & Country Director Americares India Foundation
About “World Hypertension Day”:
Celebrating World Hypertension Day all over the world was established and started by The World Hypertension League (WHL). It had started the campaign of hypertension day to increase the common public awareness about the hypertension. It aimed to fill the gap of lack of appropriate knowledge among people about the hypertension and people suffering of it. World Hypertension Day was first inaugurated in May 2005 and is celebrated every year on 17th May to raise the public awareness about the hypertension, its prevention and complications.
About Glenmark Pharmaceuticals Ltd:
Glenmark Pharmaceuticals Ltd. (GPL) is a research-driven, global, integrated pharmaceutical company headquartered at Mumbai, India. It is ranked among the top 80 Pharma & Biotech companies of the world in terms of revenues. (SCRIP 100 Rankings published in the year 2014). Glenmark is a leading player in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). Glenmark has several molecules in various stages of clinical development and is primarily focused in the areas of Inflammation [asthma/COPD, rheumatoid arthritis etc.] and Pain [neuropathic pain and inflammatory pain].
The company has a significant presence in branded generics markets across emerging economies including India. GPL along with its subsidiary has 14 manufacturing facilities in four countries and has six R&D centers. The Generics business of Glenmark services the requirements of the US and Western Europe markets. The API business sells its products in over 80 countries, including the US, various countries in the EU, South America and India.
About Americares India Foundation:
Americares is a health-focused relief and development organization that responds to people affected by poverty or disaster with life-changing health programs, medicine and medical supplies. It is India’s leading non-profit provider delivering innovative health programs and quality medical aid across the country. With a belief that health is fundamental to all aspects of human development, the organization focusses on four core areas: Emergency Response, Clinical Services, Community Health and Access to Medicine
The organization helps communities prepare for, respond to and recover from disasters. It prevents disease, promotes good health and improves clinical services in vulnerable communities. It increases access to critical medicine and medical supplies. Americares envisions a world in which all people have pathways to health and opportunity.
Everyday, Americares’ seven mobile medical clinics offer access to and continuity of primary care to marginalize populationspread across 130 clinic locations in 13 municipal wards of Mumbai city. Launched in 2011, the program works to raise awareness and inculcate positive health habits among the marginalize population of Mumbai.